245 related articles for article (PubMed ID: 33050895)
1. Population structure and pharmacogenomic risk stratification in the United States.
Nagar SD; Conley AB; Jordan IK
BMC Biol; 2020 Oct; 18(1):140. PubMed ID: 33050895
[TBL] [Abstract][Full Text] [Related]
2. Human loci involved in drug biotransformation: worldwide genetic variation, population structure, and pharmacogenetic implications.
Maisano Delser P; Fuselli S
Hum Genet; 2013 May; 132(5):563-77. PubMed ID: 23354977
[TBL] [Abstract][Full Text] [Related]
3. Ancestry-attenuated effects of socioeconomic deprivation on type 2 diabetes disparities in the All of Us cohort.
Lam V; Sharma S; Gupta S; Spouge JL; Jordan IK; Mariño-Ramírez L
Res Sq; 2023 Sep; ():. PubMed ID: 37790565
[TBL] [Abstract][Full Text] [Related]
4. Ancestry-attenuated effects of socioeconomic deprivation on type 2 diabetes disparities in the
Lam V; Sharma S; Gupta S; Spouge JL; Jordan IK; Mariño-Ramírez L
BMC Glob Public Health; 2023; 1(1):. PubMed ID: 38045036
[TBL] [Abstract][Full Text] [Related]
5. Race, Ethnicity, and Pharmacogenomic Variation in the United States and the United Kingdom.
Sharma S; Mariño-Ramírez L; Jordan IK
Pharmaceutics; 2023 Jul; 15(7):. PubMed ID: 37514109
[TBL] [Abstract][Full Text] [Related]
6. A Comparative Analysis of Genetic Ancestry and Admixture in the Colombian Populations of Chocó and Medellín.
Conley AB; Rishishwar L; Norris ET; Valderrama-Aguirre A; Mariño-Ramírez L; Medina-Rivas MA; Jordan IK
G3 (Bethesda); 2017 Oct; 7(10):3435-3447. PubMed ID: 28855283
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomic landscape of Indian population using whole genomes.
Sahana S; Bhoyar RC; Sivadas A; Jain A; Imran M; Rophina M; Senthivel V; Kumar Diwakar M; Sharma D; Mishra A; Sivasubbu S; Scaria V
Clin Transl Sci; 2022 Apr; 15(4):866-877. PubMed ID: 35338580
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population.
Verma SS; Keat K; Li B; Hoffecker G; Risman M; ; Sangkuhl K; Whirl-Carrillo M; Dudek S; Verma A; Klein TE; Ritchie MD; Tuteja S
J Transl Med; 2022 Nov; 20(1):550. PubMed ID: 36443877
[TBL] [Abstract][Full Text] [Related]
9. Leveraging genomic diversity for discovery in an electronic health record linked biobank: the UCLA ATLAS Community Health Initiative.
Johnson R; Ding Y; Venkateswaran V; Bhattacharya A; Boulier K; Chiu A; Knyazev S; Schwarz T; Freund M; Zhan L; Burch KS; Caggiano C; Hill B; Rakocz N; Balliu B; Denny CT; Sul JH; Zaitlen N; Arboleda VA; Halperin E; Sankararaman S; Butte MJ; ; Lajonchere C; Geschwind DH; Pasaniuc B
Genome Med; 2022 Sep; 14(1):104. PubMed ID: 36085083
[TBL] [Abstract][Full Text] [Related]
10. Characterization of mitochondrial haplogroups in a large population-based sample from the United States.
Mitchell SL; Goodloe R; Brown-Gentry K; Pendergrass SA; Murdock DG; Crawford DC
Hum Genet; 2014 Jul; 133(7):861-8. PubMed ID: 24488180
[TBL] [Abstract][Full Text] [Related]
11. Population Pharmacogenomics for Health Equity.
Jordan IK; Sharma S; Mariño-Ramírez L
Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895188
[TBL] [Abstract][Full Text] [Related]
12. Genetic Variation among Pharmacogenes in the Sardinian Population.
Idda ML; Zoledziewska M; Urru SAM; McInnes G; Bilotta A; Nuvoli V; Lodde V; Orrù S; Schlessinger D; Cucca F; Floris M
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077453
[TBL] [Abstract][Full Text] [Related]
13. Warfarin Pharmacogenomics in Diverse Populations.
Kaye JB; Schultz LE; Steiner HE; Kittles RA; Cavallari LH; Karnes JH
Pharmacotherapy; 2017 Sep; 37(9):1150-1163. PubMed ID: 28672100
[TBL] [Abstract][Full Text] [Related]
14. Population Diversity in Pharmacogenetics: A Latin American Perspective.
Suarez-Kurtz G; Parra EJ
Adv Pharmacol; 2018; 83():133-154. PubMed ID: 29801573
[TBL] [Abstract][Full Text] [Related]
15. Opportunities for personalizing colorectal cancer care: an analysis of SEER-medicare data.
Rivers ZT; Parsons HM; Jacobson PA; Kuntz KM; Farley JF; Stenehjem DJ
Pharmacogenomics J; 2022 May; 22(3):198-209. PubMed ID: 35361994
[TBL] [Abstract][Full Text] [Related]
16. Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology.
Shriver SP; Adams D; McKelvey BA; McCune JS; Miles D; Pratt VM; Ashcraft K; McLeod HL; Williams H; Fleury ME
J Clin Oncol; 2024 Apr; 42(10):1181-1192. PubMed ID: 38386947
[TBL] [Abstract][Full Text] [Related]
17. APOE Genotype and Alzheimer Disease Risk Across Age, Sex, and Population Ancestry.
Belloy ME; Andrews SJ; Le Guen Y; Cuccaro M; Farrer LA; Napolioni V; Greicius MD
JAMA Neurol; 2023 Dec; 80(12):1284-1294. PubMed ID: 37930705
[TBL] [Abstract][Full Text] [Related]
18. Self-reported race/ethnicity in the age of genomic research: its potential impact on understanding health disparities.
Mersha TB; Abebe T
Hum Genomics; 2015 Jan; 9(1):1. PubMed ID: 25563503
[TBL] [Abstract][Full Text] [Related]
19. The pharmacogenomic landscape of an Indigenous Australian population.
Samarasinghe SR; Hoy W; Jadhao S; McMorran BJ; Guchelaar HJ; Nagaraj SH
Front Pharmacol; 2023; 14():1180640. PubMed ID: 37284308
[No Abstract] [Full Text] [Related]
20. Frequencies of pharmacogenomic alleles across biogeographic groups in a large-scale biobank.
Li B; Sangkuhl K; Whaley R; Woon M; Keat K; Whirl-Carrillo M; Ritchie MD; Klein TE
Am J Hum Genet; 2023 Oct; 110(10):1628-1647. PubMed ID: 37757824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
